Stephanie is a Health Technology Executive and serves as Chief Knowledge Officer, leading scientific affairs at Conceivable Life Sciences, a biotech/deeptech company headquartered in New York City. She sits on the Health Advisory Board of Equinox and as Board Trustee and on the Investment Committee of The King’s Fund, the UK’s foremost healthcare think tank.

An OBGYN by training, and advocate for Women’s Health and Reproductive Healthspan, she spent over 15 years engaged in both clinical practice and research at Britain’s National Health Service and HCA Healthcare. During her clinical career Stephanie was awarded numerous international traveling fellowships including Memorial Sloane Kettering Cancer Center in New York, Cancer Hospital Pernambuco in Brazil, and Centre du Cancer Oscar Lambret in France. She was awarded a Doctorate in Clinical Research at UCL (Oncology) where she remains an Honorary Senior Research Fellow at the Institute of Women’s Health.

More recently, Stephanie served as Senior Advisor in Clinical AI/Medical devices at the World Health Organization’s Department of Digital Health & Innovation. She has also worked extensively as a Health Technology Director for a leading consultancy in digital health and artificial intelligence, leading deep due diligence and clinical/scientific validation of medical technology associated with regulatory approvals for over 50 AI & Deeptech startups at the intersection of scientific validation, product, regulatory and go-to-market strategy.

Stephanie received her medical degree from the University of Bristol, and research doctorate from University College London (UCL), UK.